chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around 9pm after the vaccine I developed a severe fever of 101.4 and extreme fatigue feeling like a truck hit me.  The fever broke within 24hrs but the fatigue lasted for days. I noticed within a few weeks after the first vaccine I begin having a flare up of the Prinz Metal Angina which caused me to have to see my Cardiologist on 2/8. I went ahead and got the 2nd vaccine and the Angina got worse which caused me to have a Cardiac Catherization on 2/22 to verify it was in fact the Angina and no damage was there but increased coronary artery disease was detected which I feel is no relation to the vaccine and is more hereditary. Ranexa medication was increased and Amlodipine was added and the Angina is now controlled again. I went to PT which has helped me get stronger, but  still to date I have episodes of where I develop a headache, sore throat, get very fatigued, the feeling of a fever continues off and on. On 8/1 I felt so sick feeling like I had COVID I went got another COVID test which was negative. The cough still lingers which causes a sore throat. 7/28 I had a EGD to see if it was reflux, but a tiny benign mass was found. The reflux was very low so its not believe to be the source of the cough. So now a 2nd EGD is scheduled for 9/13. I take Nyquil nightly to help me sleep because the symptoms can get so severe at night.
patient developed dizziness within minutes of receiving 2nd dose of moderna (no reaction to the 1st dose).   She complained of difficulty breathing, she was sweating, shivering/ shaking, complained of feeling cold. She was placed on the floor on her right side, and I monitored her vital signs while calling 911. Her blood pressure and pulse were normal.  BP 110/70, second reading BP 100/65. Paramedics arrived very quickly and transported patient to the hospital.
Patient felt muscle weakness in legs and arms, has very high blood pressure and fast heart rate after attempting to do mild exercise.  also experience extreme tiredness.   symptoms lasted about a week
The patient developed hives on her trunk and both legs within 10 min after being vaccinated. The patient was kept in the office for over 30 min for observation, no additional symptoms developed and hives did not worsen or spread  to other areas of her body.  Patient's mother was given instructions to monitor for signs of anaphylaxis  and instructed to call 911 if these symptoms developed.
This spontaneous report was received from a physician and office manager and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses GARDASIL 9 (dose, route of administration, lot# and expiration date were not reported). The vaccine was reconstituted with properly stored sterile diluent (manufacturer unknown) (lot# and expiration date were not reported). No adverse effect reported. Administered doses of vaccines experienced the temperature excursion between 47 and 77 degrees Fahrenheit for 2 hours. Data logger was involved. There were no previous excursions reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-00507513-1706USA011670: US-00507513-1706USA011669: US-00507513-1706USA011307: US-00507513-1706USA011668.
I didn't recognize my symptoms at first. I experienced body chills, mild fatigue, mild muscle ache. I did not have a fever, nor did I lose my taste or smell. I did an at home COVID-19 test, which came back positive. I quarantined and called my doctor who stated that I needed to remain quarantined for five days since I first started feeling symptoms and wore a mask afterwards. I continued to test positive for three weeks, then I tested negative after that time period.
Hypoplastic left heart syndrome; This is a spontaneous report from a contactable consumer (patient's father). A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 05Feb2021 (reported as in the afternoon, after 1400) (Batch/Lot Number: EN5318) (at the age of 33-years-old) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included heart issue with her heart from an unknown date, several heart surgeries from an unknown date. There were no additional vaccines administered on same date of the Pfizer Suspect. Prior Vaccinations (within 4 weeks) was none. There was no family medical history relevant to AE. Concomitant medication included ASPIRIN [acetylsalicylic acid] tablet taken for an unspecified indication, start and stop date were not reported. The consumer stated he did not keep close contact on all her medications since she was not living with her parents. The patient experienced hypoplastic left heart syndrome on an unspecified date and died for it on 08Feb2021. The consumer was reporting that his daughter passed away after she got the first Pfizer covid shot. She passed away in February. She got her shot on a Friday and passed away Monday evening. She did have a heart issue with her heart. At the time she had been through several heart surgeries and they did not realize the covid vaccine had issues for cardiac patients. The vaccine was recommended by her doctors. He reported she had hypoplastic left heart syndrome and that was the cause of death. She died on 08Feb2021. She died in her sleep, between 12:30am and 7:30am on 08Feb2021. She did not have an autopsy done at the time. He reported she had just got the shot and he was not sure if she died from natural causes or from the shot. In his heart he felt like she had been cut up enough and did not have an autopsy done. If he knew then the information that he knew now, then he would have had an autopsy done. She received vaccine basis that of her doctor's recommendation and her mother's panic about her covid and dyeing an ugly death, she had two cardiovascular surgeons that both recommended to get the covid vaccine. There was no Emergency Room visit and no physician office visit. The patient died on 08Feb2021.  An autopsy was not performed. The outcome of the event hypoplastic left heart syndrome was fatal.; Reported Cause(s) of Death: Hypoplastic left heart syndrome
This spontaneous report as received from a Nurse Practitioner refers to a patient of unknown age. The reporter reported that the patient was vaccinated with GARDASIL (lot# was unknown) on the following dates: 27-JUL-/2007, 11-DEC-2008, 05-SEP-2012. No adverse effect was reported. Additional information has been requested.
15 month old baby was given Kinrix; Baby was given kinrix instead of infanrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old female patient who received DTPa-IPV (Kinrix) (batch number H9FM5, expiry date 7th May 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included PNEUMOCOCCAL VACCINE.   On 9th June 2022, the patient received Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 9th June 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-JUN-2022 Reporter's Comment: The reporter was the office manager and a medical assistant at a pediatric office.  She reported that, the patient was given the wrong vaccine.  She was supposed to receive unspecified pneumococcal (non-GSK) and DTaP ( Infanrix) but instead received unspecified pneumococcal (non-GSK) and DTaP + IVP (Kinrix). The Vaccine Administration Facility was the same as primary Reporter. The reporter consented to follow up. Additional Supportive Information: The patient received Kinrix instead of Infanrix at the age of 15 months, which led to inappropriate age at vaccine administration and wrong vaccine administered.
Information has been received from a study for ROTATEQ concerning a 17 week old male who was vaccinated with a second dose of ROTATEQ. Eight days after vaccination, the infant was with one day of nausea, vomiting and fussiness. Pediatrician referred him to ED for ultrasound. On 14-AUG-2007 the patient was hospitalized. Ileocolic intussusception was confirmed by ultrasound and hydrostatically reduced via barium enema. The infant was discharged home next day. At the time of reporting, the outcome was unknown. Ileocolic intussusception was considered to be an other important medical event. The relationship of intussusception to ROTATEQ was not reported. Additional information is not expected.
Child devloped a fever (101 degrees Fahrenheit). Vomiting one time. Restlessness. Lasted over 24 hours. Continues to be lethargic at this time with no appetite.
ALTE- mother found infant unresponsive in crib.  Took to ER, recovered on way.  Minimal work-up performed
Swollen lymph nodes around the breast area which always come and go; Redness; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program.  A 47 year-old female patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) at the age of 46 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "not recovered", described as "Swollen lymph nodes around the breast area which always come and go"; ERYTHEMA (non-serious), outcome "not recovered", described as "Redness".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Information has been received from a medical assistant concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL (route and administration site not reported) at another office. Subsequently the patient experienced an allergic reaction after receiving GARDASIL. Subsequently, the patient recovered from the allergic reaction. The patient sought medical attention by seeing a physician. Additional information has been requested.
Within 24 hours of the injection I had severe pain in the upper right quadrant in addition to body and muscle aches. This subsided within 10 hours but continued as a bad IBS attack. In addition I had neuralgia and nerve aches which over time became severe muscle aches and joint pain. I am currently 3 months out from the injection and am not symptom free. I still have joint pain, shakiness, weakness, and fatigue. It seems like it is slowly improving.
I started feeling subtle flu-like symptoms about 6 hours after receiving shot. At first I thought it was in my head but by the early evening I felt like I had a full blown fever even though I never actually had a fever at any point.  I had chills, muscles aches, head aches, and extreme fatigue. My back hurt especially and overall I felt very weak. I also had pain at the injection site that got worse the following day. I had trouble even lifting my arm to reach a drink just a few feet away from me.  The arm soreness lasted through the Monday following my vaccination (I received it on a Friday). All my symptoms were at their worst on Saturday. I felt much better on Sunday but still had the arm pain through Monday. Motrin did help relieve the worst my symptoms. I thought that was the end of my symptoms but that last week I have noticed what I believe to be a lingering fatigue from the vaccination. While it's not usual for me to feel tired at points throughout the day, I have been feeling a heavier and more full body fatigue than I usually experience. I have had to take naps more often, sometimes multiple times in a day.  During these bouts of fatigue, my whole body feels heavy and somewhat weak. It's similar to the exhausted feeling someone might have after they've been crying for a while but I haven't been crying or emotionally taxed in anyway.  Normally when I wake up in the morning, I might feel tired for the first 30 minutes to an hour but once I get moving, I feel better and more alter. I have been having a harder time feeling rested or awake in the mornings and even if I get more sleep than normal, I still feel exhausted. I did not change my routine or diet which I why I think this is related to the vaccine.
Anemic; CRAMPING; FREQUENCY AND URGENCY TO USE BATHROOM/DIARRHEA ALL TIME; This spontaneous case was reported by a consumer and describes the occurrence of ANAEMIA (Anemic), MUSCLE SPASMS (CRAMPING) and DIARRHOEA (FREQUENCY AND URGENCY TO USE BATHROOM/DIARRHEA ALL TIME) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 4782590 and 4782590) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    NO KNOWN ALLERGIES.  Concurrent medical conditions included Blood pressure and Ulcerative colitis. Concomitant products included MESALAMINE for Ulcerative colitis, ZOLPIDEM TARTRATE (STILNOX) and LOSARTAN POTASSIUM for an unknown indication.   On 01-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2022, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 160 milligram every two weeks. On 20-May-2022, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 80 milligram. In June 2022, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 40 milligram every two weeks. On an unknown date, the patient experienced ANAEMIA (Anemic), MUSCLE SPASMS (CRAMPING) and DIARRHOEA (FREQUENCY AND URGENCY TO USE BATHROOM/DIARRHEA ALL TIME). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and IRON at an unspecified dose and frequency. At the time of the report, ANAEMIA (Anemic) and MUSCLE SPASMS (CRAMPING) had not resolved and DIARRHOEA (FREQUENCY AND URGENCY TO USE BATHROOM/DIARRHEA ALL TIME) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-May-2022, Haemoglobin: 8.9. On an unknown date, Colonoscopy: Ulcerative colitis.         It was unknown if patient was enrolled in COVID-19-Vaccine Trial.  The reporter's causality for the events of anemic, cramping, frequency and urgency to use bathroom/diarrhea all time and humira not helping for low hemoglobin level with adalimumab solution for injection was not provided.  Abbvie's opinion was that the causality for the events of anemic, cramping, frequency and urgency to use bathroom/diarrhea all time and humira not helping for low hemoglobin level with adalimumab solution for injection was not provided.
Metallic taste in mouth, then itch palate, then hives of palate per nurse at testing site.
Fever of 104F, 30 minutes, post vax. Was dizzy, weak and had a runny nose. High fever of 104F persisted for 24 hours after event.
Information has been received from a physician concerning a female patient who on an unknown date was vaccinated with a second dose of Gardasil.  Subsequently, the patient experienced significant pain around the injection site which lasted for a week or longer after receiving the vaccine.  Unspecified medical attention was sought.  It was also reported that the same reaction occurred after the first dose of Gardasil.  No product quality complaint was involved.  Additional information has been requested.
atrial fibrillation; had Moderna COVID-19 vaccination and the shingles shot, one in each arm, both were painful; Diarrhea; Nausea; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4483452-00.  A 64-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose number unknown (booster), single (Batch/Lot number: unknown) intramuscular, in arm for covid-19 immunisation; ibrutinib (IMBRUVICA), (Batch/Lot number: unknown), oral for chronic lymphocytic leukaemia; varicella zoster vaccine rge (cho) (SHINGRIX), (Batch/Lot number: unknown), in arm for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown"; VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "had Moderna COVID-19 vaccination and the shingles shot, one in each arm, both were painful"; DIARRHOEA (non-serious), outcome "unknown", described as "Diarrhea"; NAUSEA (non-serious), outcome "unknown". The action taken for ibrutinib was unknown.  The reporter considered "atrial fibrillation", "had moderna covid-19 vaccination and the shingles shot, one in each arm, both were painful", "diarrhea" and "nausea" related to BNT162b2.  Clinical Course: Causality for Imbruvica, the reporter's causality for the event(s) of Had Moderna Covid-19 Vaccination and The Shingles Shot, One in each Arm, Both were painful, Atrial Fibrillation, Diarrhea and Nausea was not provided and Causality for Moderna Covid-19 Vaccine, causality for events reported as Possible. Causality for Pfizer Biontech COVID-19 Vaccine, causality for the events reported as Possible and for shingrix, events causality reported as Possible. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Primary reporter did not have the lot number information, because the packaging was discarded.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Based on the information in the case, an association between the reported events atrial fibrillation, vaccination site pain, diarrhea and nausea and the suspect product bnt162b2 cannot be ruled out.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
pt broke out in tiny vessicles entire border & fever;rx'd w/DPH;scabbing over 16JUN97;
We scheduled a large family that arrived at our drive-thru event in different cars - Patient was in the last care of our drive-thru event of the day.  We had not been told before hand that anyone was under 19 (our previous cut-off).  Honestly, we checked her ID and went through the routine questions prior to injection - and we had all heard around this time that vaccines were now good for 16 and older and so we vaccinated her with a first dose of Moderna.  We realized when the data was placed into system that we had made this mistake.
injection site pain; injection site redness; Injection site swollen; injection site warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site pain), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE WARMTH (injection site warm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013MWA) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (injection site pain), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE WARMTH (injection site warm). At the time of the report, VACCINATION SITE PAIN (injection site pain), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE WARMTH (injection site warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I have developed a bald spot on the top of my head. It is on the right side of the top of my head in line with my right ear. It is approximately a 1 inch diameter circle. It started soon after receiving my first shot. About 6 weeks later, it my hair has not grown back.
I have a burning and feeling of wetness on my face, back, neck, legs and arms. It is constant.  The burning is hardly bearable.
SLEEP RELATED HYPOVENTILATION OR HYPOXEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE HYPERCAPNIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Fatigue; This is a spontaneous report received from contactable reporter(s) (Other HCP). Other Case identifier(s): LRN4778411.  A female patient received BNT162b2 (BNT162B2), on 12Oct2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (ongoing), notes: concurrent condition. Concomitant medication(s) included: OCREVUS. The following information was reported: FATIGUE (non-serious) with onset 12Oct2021, outcome "recovered".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.